East Asia’s biotech autonomy push is already stunting innovation

The US-China technology rivalry is expanding into biotechnology, with export controls and investment restrictions opening a new front in strategic

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.